A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase- polymerase chain reaction

Blood

Volumn 92, Issue 8, 1998, Pages 2844-2855

  Szczepek, Agnieszka J ^b   Seeberger, Karen ^b   Wizniak, Juanita ^b   Mant, Michael J ^b   Belch, Andrew R ^b   Pilarski, Linda M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN HEAVY CHAIN;

ARTICLE; B LYMPHOCYTE; CELL SELECTION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE REARRANGEMENT; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MOLECULAR CLONING; MULTIPLE MYELOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032531999     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.8.2844.420k17_2844_2855     Document Type: Article

References (57)

1. Barlogie B, Epstein J, Selvanayagam P, Alexanian R: Plasma cell myeloma - New biological insights and advances in therapy. Blood 73:865, 1989
2. 1A. Szczepek AJ, Belch AR, Pilarski LM: Differential expression of CD19 epitopes distinguishes circulating clonotypic B cells from residual polyclonal B cells in multiple myeloma, (in preparation)
3. Greipp PR: Advances in the diagnosis and management of myeloma. Semin Hematol 29:24, 1992
4. Pilarski LM, Jensen GS: Monoclonal circulating B cells in multiple myeloma: A continuously differentiating possibly invasive population as defined by expression of CD45 isoforms and adhesion molecules. Hematol Oncol Clin North Am 6:297, 1992
5. Bergsagel PL, Masellis S, Szczepek A, Mant MJ, Belch AR, Pilarski LM: In multiple myeloma, clonotypic B lymphocytes are detectable among CD19 + peripheral blood cells expressing CD38, CD56 and monotypic immunoglobulin light chain. Blood 85:436, 1995
6. Pilarski LM, Masellis S, Szczepek A, Mant MJ, Belch AR: Circulating clonotypic B cells in the biology of myeloma. Speculations on the origin of multiple myeloma. Leuk Lymphoma 22:375, 1996
7. Jensen GS, Mant MJ, Belch AR, Berensen JR, Ruether BA, Pilarski LM: Selective expression of CD45 isoforms defines CALLA+ monoclonal B lineage cells in peripheral blood from myeloma patients as late stage B cells. Blood 78:711, 1991
8. Billadeau D, Ahmann G, Greipp P, Van Ness B: The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J Exp Med 178:1023, 1993
9. Takashita M, Kosaka M, Goto T, Saito S: Cellular origin and extent of clonal involvement in multiple myeloma: Genetic and phenotypic studies. Br J Haematol 87:735, 1994
10. Bakkus MHC, Van Riet I, Van Camp B, Thielemann K: Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatiailly mutated B cell. Br J Haematol 87:68, 1994
11. Omedè P, Tarella C, Palumbo A, Argentine C, Caracciolo D, Corradini P, Dominietto A, Giaretta F, Ravaglia R, Triolo R, Triolo S, Pileri A, Boccadoro M: Multiple myeloma: Reduced plasma cell contamination in peripheral blood progenitor cell collections performed after repeated high-dose chemotherapy courses. Br J Haematol 99:685, 1997
12. Boccadoro M, Gavarotti P, Fossati G, Mussaia M, Pilieri A, Durie BGM: Kinetics of circulating B lymphocytes inhuman myeloma. Blood 61:812, 1983
13. Hulin N, Conte PF, Pileri A: Biology of the human myeloma cell population. II. Cytokinetic characteristics. Ric Clin Lab 8:49, 1978
14. Caligaris-Cappio F, Bergui L, Gregoretti MG, Gaidano G, Gaboli M, Schena M, Zallone AZ, Marchisio PC: Role of bone marrow stromal cells in the growth of human multiple myeloma. Blood 77:2688, 1991
15. Berenson JR, Lichtenstein AK: Clonal rearrangement of immunoglobulin genes in the peripheral blood of multiple myeloma patients. Br J Haematol 73:425, 1989
16. Berenson J, Wong R, Kim K, Brown N, Lichtenstein A: Evidence for peripheral blood B lymphocyte but not T lymphocyte involvement in multiple myeloma. Blood 70:1550, 1987
17. Billadeau D, Quam L, Thomas W, Kay NE, Greipp P, Kyle R, Oken MM, Van Ness B: Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood 80:1818, 1992
18. Billideau D, Van Ness B, Kimlinger T, Kyle RA, Therneau TM, Greipp PR, Witzig TE: Clonal circulating cells are common in plasma cell proliferative disorders: A comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma. Blood 88:289, 1996
19. Corradini P, Voena C, Omede P, Astolfi M, Boccadoro M, Dalla-Favera R, Pilieri A: Detection of circulating tumor cells in multiple myeloma by a PCR based method. Leukemia 7:1879, 1993
20. Gazitt Y, Reading CC, Hoffman R, Wickrema A, Vesole D, Jagannath S, Condino J, Lee B, Barlogie B, Tricot G: Purified CD34 + Lin-Thy+ stem cells do not contain clonal myeloma cells. Blood 86:381, 1995
21. Cassel A, Leibovitz N, Hornstein L, Quitt M, Aghai E: Evidence for the existence of circulating monoclonal B-lymphocytes in multiple myeloma patients. Exp Hematol 18:1171, 1990
22. Dreyfus F, Melle J, Quarre C, Pillier C: Contamination of peripheral blood by monoclonal B cells following treatment of multiple myeloma by high dose chemotherapy. Br J Hematol 85:411, 1993
23. Corradini P, Voena C, Astolfi M, Ladetto M, Tarella C, Boccadoro M, Pilieri A: High dose sequential chemotherapy in multiple myeloma: Residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting. Blood 85:1596, 1995
24. Chen BJ, Epstein J: Circulating clonal lymphocytes in myeloma constitute a minor population of B cells. Blood 87:1972, 1996
25. Szczepek AJ, Bergsagel PL, Axelsson L, Brown CB, Belch AR, Pilarski LM: CD34+ cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient-specific IgH VDJ rearrangements. Blood 89:1824, 1997
26. Pilarski LM, Szczepek AJ, Belch AR: Deficient drug transporter function of bone marrow-localized and leukemic plasma cells in multiple myeloma, Blood 90:3751, 1997
27. Pilarski LM, Szczepek A, MacDonald H, Mam MJ, Belch AR: Single cell IgH CDR3 and in situ RT-PCR for IgH CDR3 and Ig light chain unequivocally confirm that circulating CD19+ cells in multiple myeloma are B cells. Blood 86:58a, 1995 (abstr)
28. Pilarski LM, Mant MJ, Belch AR: Circulating, monoclonal, multi-drug resistant B cells may comprise the malignant stem cells population in multiple myeloma, Ares Serono Symposia. Rome, Italy, in Dammaco F, Barlogie B (eds): Challenges in Modern Medicine vol 4, 1994, p 31
29. Pilarski LM. Belch AR: Circulating monoclonal B cells expressing p-glycoprotein may be a reservoir of multidrug resistant disease in multiple myeloma. Blood 83:724, 1994
30. Pilarski LM, Masellis Smith A, Belch AR, Yang B, Savani RC, Turley EA: RHAMM, a receptor for hyaluronan-mediated motility, on normal lymphocytes, thymocytes and in B cell malignancy: A mediator in B cell malignancy? Leuk Lymphoma 14:363, 1994
31. Masellis-Smith A, Belch AR, Mant MJ, Turley EA, Pilarski LM: Hyaluronan-dependent motility of B cells and leukemic plasma cells but not of bone marrow plasma cells in multiple myeloma: Alternate usage of RHAMM and CD44. Blood 87:1891, 1996
32. Masellis S, Belch AR, Mam MJ, Pilarski LM: Adhesion of multiple myeloma peripheral blood B cells to bone marrow fibroblasts: a requirement for CD44 and a 4β7. Cancer Res 57:930, 1997
33. Pilarski LM, Belch AR: Intrinsic expression of the multidrug transporter, P-glycoprotein 170, in multiple myeloma: Implications for treatment. Leuk Lymphoma 17:367, 1995
34. Frickhoven N, Muller E, Sandherr M, Binder T, Baumgartner M, Wiest C, Enz M, Heimpel H: Rearranged Ig heavy chain is detectable in cell-free blood samples of patients with B cell neoplasia. Blood 90:4953, 1998
35. Pietersz GA, Li WJ, Sutton VR, Burgess J, McKenzie IFC, Zola H, Trapani JA: In vitro and in vivo antitumor-activity of a chimeric anti-CD19 antibody. Cancer Immunol Immunother 41:53, 1995
36. Zola H, McCardle PJ, Bradford T, Weedon H, Yasui H, Kurosawa Y: Preparation and characterization of a chimeric CD 19 monoclonal antibody. Immunol Cell Biol 69:411, 1991
37. Pilarski LM, Szczepek AJ, Mant MJ, Belch AR: Cryptic expression of the CD 19 epitope detected by MoAb Leu 12 distinguishes malignant from residual polyclonal B cells in the blood of myeloma patients. Blood 90:349a, 1997 (abstr)
38. Aubin J, Davi F, Nuguyen-Salomon F, Leboeuf D, Debert C, Tuner M, Valensi F, Canioni D, Brousse N, Varet B, Fladrin G, Macintyre EA: Description of a novel FR1 IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies. Leukemia 9:471, 1995
39. Witzig TE, Dhodapkar MV, Kyle RA, Greipp PR: Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma. Cancer 72:108, 1993
40. Witzig TE, Kimlinger TK, Ahmann GJ, Katzmann JA, Greipp PR: Detection of myeloma cells in the peripheral blood by flow cytometry. Cytometry 26:113, 1996
41. Demaison C, David D, Letourneur F, Theze J, Saragosti S, Zouali M: Analysis of human VH gene repertoire expression in peripheral CD19+ B cells, Immunogenetics 42:342, 1995
42. Brezinschek HP, Brezinschek RI. Lipsky PE: Analysis of the heavy chain repertoire of human peripheral B cells using single cell polymerase chain reaction. J Immunol 155:190, 1995
43. Davidkova G, Petterson S, Holmberg D, Lundkvist I: Selective use of VH genes in adult human B lymphocyte repertoires. Scand J Immunol 45:62, 1997
44. Vescio RA, Hong CH, Cao J, Kim A, Schiller GJ, Lichtenstein AK, Berenson RJ, Berenson JR: The hematopoietic stem cell antigen CD34 is not expressed on the malignant cells in multiple myeloma. Blood 84:3283, 1994
45. Kimlinger T, Witzig TE: Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma. Bone Marrow Transplant 19:553, 1997
46. Pilarski LM, Mam MJ, Ruether BA, Belch AR: Severe deficiency of B lymphocytes in peripheral blood from multiple myeloma patients. J Clin Invest 74:1301, 1984
47. Pilarski LM, Ruether BA, Mant MJ: Abnormal function of B lymphocytes from peripheral blood of multiple myeloma patients. I. Lack of correlation between the number of cells potentially able to secrete IgM and serum IgM levels. J Clin Invest 75:2024, 1985
48. Pilarski LM, Andrews EJ, Mant MJ, Ruether BA: Humoral immune deficiency in multiple myeloma patients due to compromised B cell function. J Clin Immunol 6:491, 1986
49. Pilarski LM, Andrews EJ, Serra HM, Ledbetter JA, Ruether BA, Mant MJ: Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstroms macroglobulinemia, multiple myeloma and I IgM monoclonal gammopathy of undetermined significance. Am J Hematol 30:53, 1989
50. Pilarski LM, Andrews EJ, Serra HM, Ruether BA, Mant MJ: Comparative analysis of immunodeficiency between patients with gammopathy of undetermined significance and patients with untrested myeloma. Scand J Immunol 29:217, 1989
51. Pilarski LM, Mant MJ, Ruether BA: Review: Analysis of immunodeficiency in multiple myeloma: Observations and hypothesis. J Clin Lab Anal 1:214, 1987
52. Yamada M, Wasserman R, Reichard BA, Shane S, Caton AJ, Rovera G: Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes. J Exp Med 173:395, 1991
53. Pilarski LM, Piotrowska-Krezolek M, Gibney DJ, Winger L, Winger C, Mant MJ, Ruether BA: Specificity repertoire of lymphocytes from multiple myeloma patients. I. High frequency of B cells specific for idiotypic and F(ab')2 region determinants on immunoglobulin. J Clin Immunol 5:275, 1985
54. Jensen GS, Belch AR, Kherani F, Mant MJ, Ruether BA, Pilarski LM: Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients. Scand J Immunol 36:843, 1992
55. Brown R, Luo XF, Gibson J, Morley A, Sykes P, Brisco M, Joshua D: Idiotypic oligonucleotide probes to detect myeloma cells by mRNA in situ hybridization. Br J Haematol 90:113, 1998
56. Kay NE, Oken MM, Bone N, Kyle RA, Greipp P, Van Ness B, Leong T: Circulating CD19+ blood cells in myeloma. Blood 86:4000, 1995
57. Bergsagel PL, Belch AR, Pilarski LM: The blood B cells and bone marrow plasma cells in a patient with multiple myeloma include cells with the same N-ras mutation Blood 84:524a, 1994 (abstr)